Michele L Okun1,2, Daniel J Buysse1,3, Martica H Hall1,3. 1. School of Medicine, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA. 2. University of Colorado, Colorado Springs, CO. 3. Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA.
Abstract
STUDY OBJECTIVES: Although a substantial number of pregnant women report symptoms of insomnia, few studies have used a validated instrument to determine the prevalence in early gestation. Identification of insomnia in pregnancy is vital given the strong connection between insomnia and the incidence of depression, cardiovascular disease, or immune dysregulation. The goal of this paper is to provide additional psychometric evaluation and validation of the Insomnia Symptom Questionnaire (ISQ) and to establish prevalence rates of insomnia among a cohort of pregnant women during early gestation. METHODS: The ISQ was evaluated in 143 pregnant women at 12 weeks gestation. The internal consistency and criterion validity of the dichotomized ISQ were compared to traditional measures of sleep from sleep diaries, actigraphy, and the Pittsburgh Sleep Quality Index using indices of sensitivity, specificity, positive and negative predictive value (PPV, NPV), and likelihood ratio (LR) tests. RESULTS: The ISQ identified 12.6% of the sample as meeting a case definition of insomnia, consistent with established diagnostic criteria. Good reliability was established with Cronbach α = 0.86. The ISQ had high specificity (most > 85%), but sensitivity, PPV, NPV, and LRs varied according to which sleep measure was used as the validating criterion. CONCLUSIONS: Insomnia is a health problem for many pregnant women at all stages in pregnancy. These data support the validity and reliability of the ISQ to identify insomnia in pregnant women. The ISQ is a short and cost-effective tool that can be quickly employed in large observational studies or in clinical practice where perinatal women are seen. COMMENTARY: A commentary on this article appears in this issue on page 593.
STUDY OBJECTIVES: Although a substantial number of pregnant women report symptoms of insomnia, few studies have used a validated instrument to determine the prevalence in early gestation. Identification of insomnia in pregnancy is vital given the strong connection between insomnia and the incidence of depression, cardiovascular disease, or immune dysregulation. The goal of this paper is to provide additional psychometric evaluation and validation of the Insomnia Symptom Questionnaire (ISQ) and to establish prevalence rates of insomnia among a cohort of pregnant women during early gestation. METHODS: The ISQ was evaluated in 143 pregnant women at 12 weeks gestation. The internal consistency and criterion validity of the dichotomized ISQ were compared to traditional measures of sleep from sleep diaries, actigraphy, and the Pittsburgh Sleep Quality Index using indices of sensitivity, specificity, positive and negative predictive value (PPV, NPV), and likelihood ratio (LR) tests. RESULTS: The ISQ identified 12.6% of the sample as meeting a case definition of insomnia, consistent with established diagnostic criteria. Good reliability was established with Cronbach α = 0.86. The ISQ had high specificity (most > 85%), but sensitivity, PPV, NPV, and LRs varied according to which sleep measure was used as the validating criterion. CONCLUSIONS:Insomnia is a health problem for many pregnant women at all stages in pregnancy. These data support the validity and reliability of the ISQ to identify insomnia in pregnant women. The ISQ is a short and cost-effective tool that can be quickly employed in large observational studies or in clinical practice where perinatal women are seen. COMMENTARY: A commentary on this article appears in this issue on page 593.
Authors: Michele L Okun; James F Luther; Stephen R Wisniewski; Dorothy Sit; Beth A Prairie; Katherine L Wisner Journal: J Womens Health (Larchmt) Date: 2011-10-03 Impact factor: 2.681
Authors: Thomas Roth; Catherine Coulouvrat; Goeran Hajak; Matthew D Lakoma; Nancy A Sampson; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh; Ronald C Kessler Journal: Biol Psychiatry Date: 2010-12-31 Impact factor: 13.382
Authors: Lars E Laugsand; Bjørn Olav Asvold; Lars J Vatten; Pål R Romundstad; Rune Wiseth; Kristian Hveem; Imre Janszky Journal: Eur J Prev Cardiol Date: 2011-07-20 Impact factor: 7.804
Authors: Sheela Toprani; Kimford J Meador; Chelsea P Robalino; Carrie Anne Brown; Abigail G Matthews; Elizabeth E Gerard; Patricia Penovich; Evan Gedzelman; Jennifer Cavitt; Sean T Hwang; Laura A Kalayjian; Maria Sam; Alison Pack; Page B Pennell Journal: Neurology Date: 2022-07-19 Impact factor: 11.800
Authors: Yassar Al-Jahdali; Maliha Nasim; Noha Mobeireek; Anwar Ahmed; Mohammad A Khan; Adnan Al-Shaikh; Yosra Ali; Abdullah Al-Harbi; Hamdan Al-Jahdali Journal: Oman Med J Date: 2020-06-21
Authors: Laura Palagini; Alessandra Bramante; Chiara Baglioni; Nicole Tang; Luigi Grassi; Ellemarije Altena; Anna F Johann; Pierre Alexis Geoffroy; Giovanni Biggio; Claudio Mencacci; Verinder Sharma; Dieter Riemann Journal: Arch Womens Ment Health Date: 2022-04-13 Impact factor: 4.405